What is Nanobiotix's share price today?
Nanobiotix (NBTX) share price today is $35.48 as of September 15, 2026 at 9:23 PM IST. The stock touched a day high of $36.76 and a day low of $35.39.What exchange does Nanobiotix stock trade on, and under what ticker symbol?
Nanobiotix stock trades on NASDAQ under the ticker symbol NBTX.What is Nanobiotix's market capitalization?
Nanobiotix's market capitalization is $1.88B as of September 15, 2026 at 9:23 PM IST.What is Nanobiotix's price-to-earnings (P/E) ratio?
Nanobiotix's price-to-earnings (P/E) ratio is N/A as of September 15, 2026.What is Nanobiotix's price-to-book (P/B) ratio?
Nanobiotix's price-to-book (P/B) ratio is 65.01 as of September 15, 2026.Can Indian investors buy Nanobiotix shares?
Yes, You can buy Nanobiotix shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.How can I invest in Nanobiotix shares from India?
Indian investors can buy Nanobiotix shares in three steps: 1. Search Nanobiotix on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.How does USD-INR currency movement affect returns from Nanobiotix shares for Indian investors?
Since Nanobiotix trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.What is the minimum amount required to invest in Nanobiotix shares via Tickertape?
Indian investors can start investing in Nanobiotix (NBTX) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 0.2817 shares at the current price of $35.48.
$
₹
$35.480.67% (-0.24)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
1D
1W
1M
1Y
5Y
Max
Key Metrics
Key Metrics
PE TTM
PE TTM
Close price divided by the earnings per share for the trailing twelve months
—
PB
PB
Close price divided by the book value per share at the end of the most recent quarter
65.01
EPS TTM
EPS TTM
Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)
$-0.58
PEG Ratio
PEG Ratio
Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years
—
Profit Margin
Profit Margin
Net profit divided by the total revenue for the most recent financial year
-73.52%
Dividend Yield
Dividend Yield
Annual dividend per share for the trailing twelve months divided by the close price
—
Analyst Ratings & ForecastAnalyst Ratings & Forecast
Analyst Ratings & Forecast
Analyst Ratings & Forecast
Based on 4 analysts' reports
Buy3 analysts
Hold1 analyst
Sell0 analyst
Analysts expect a +26.63% price upside over the next year
Current Price$35.48
Target Price$45.24
Company Profile
Peers
Peers
ABBV
P/E Ratio
72.42
72.42
1Y Return
19.00%
19.00%
Buy Reco %
57.14
57.14
AMGN
P/E Ratio
23.42
23.42
1Y Return
40.02%
40.02%
Buy Reco %
46.87
46.87
P/E Ratio
—
—
1Y Return
30.09%
30.09%
Buy Reco %
63.33
63.33
P/E Ratio
30.03
30.03
1Y Return
32.12%
32.12%
Buy Reco %
52.94
52.94
P/E Ratio
19.34
19.34
1Y Return
38.79%
38.79%
Buy Reco %
76.00
76.00
Peers & Comparison
Peers & Comparison
HealthcareBiotechnology
Valuation
Returns
Forecast
| Stock | PE TTMPE TTM | PBPB | PEG RatioPEG Ratio |
|---|---|---|---|
| Nanobiotix | - | 65.01 | - |
| AbbVie Inc | 72.42 | 50.45 | 0.52 |
| Amgen Inc | 23.42 | 17.45 | 2.27 |
Price Comparison
Price Comparison
1 Month
1 Year
5 Years
Financials
Financials
Income
Balance Sheet
Cash Flow
Quarterly Normal View
Q4 2024
Q1 2025
Q2 2025
Q4 2025
Revenue
Net Income
| Financial Year | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q4 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 3.44 | 3.29 | 16.45 | - | 32.91 | 9.28 | - | -16.47 | 26.63 | 3 |
| Gross Profit | 3.44 | 3.29 | 16.45 | - | 32.91 | 9.28 | - | -16.47 | 26.63 | 3 |
| Net Income | -30.68 | -28.09 | -5.80 | - | -11.60 | -21.87 | - | -46.26 | -5.38 | -18.57 |
| Net Profit Margin | -890.16% | -853.29% | -35.24% | - | -35.24% | -235.46% | - | 280.72% | -20.20% | -618.23% |